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Summary
Background:The study set out to identify clin-
ical, laboratory and radiological predictors of early
mortality after an acute ischaemic stroke (AIS) and
to analyse medical and neurological complications
that caused death.
Methods: A total of 479 consecutive patients
(mean age 63 ± 14 years) with AIS underwent
stroke examination and treatment. Examination
included clinical evaluation, laboratory tests, and
brain CT and/or MRI. Follow-up data at 30 days
were available for 467 patients (93%) who were
included in the present analysis.
Results: The median National Institute of
Health Stroke Study (NIHSS) score on admission
was 6. A total of 62 patients (13%) died within 30
days.The cause of death was the initial event in 43
(69%), pneumonia in 12 (19%), intracerebral
haemorrhage in 9 (15%), recurrent stroke in 6
(10%),myocardial infarction in 2 (3%), and cancer
in 1 (2%) of the patients.
In univariate comparisons, advanced age
(p <0.001), hypertension (p = 0.013), coronary dis-
ease (p = 0.001), NIHSS score (p <0.001), undeter-
mined stroke etiology (p = 0.031), relevant co-
morbidities (p = 0.008), hyperglycemia (p <0.001),
atrial fibrillation (p <0.001), early CT signs of isch-
emia (p <0.001), dense artery sign (p <0.001), prox-
imal vessel occlusion (p <0.001), and thrombolysis
(p = 0.008) were associated with early mortality. In
multivariate analysis, advanced age (HR = 1.12;
95% CI 1.05–1.19; p<0.001) and high NIHSS
score on admission (HR = 1.15, 95% CI 1.05–
1.25; p = 0.002) were independent predictors of
early mortality.
Conclusions: We report 13% mortality at 30
days after AIS. More than two thirds of the deaths
are related to the initial stroke. Advanced age and
high NIHSS score are the only independent pre-
dictors of early mortality in this series.
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Introduction
Despite significant achievements in the acute
management and treatment of stroke, it remains
the third leading cause of death in industrialised
countries [1, 2]. Nowadays, up to 10% of patients
with an acute ischaemic stroke die within 30 days
of the ictus [3].The identification of early mortal-
ity predictors is of paramount importance for cli-
nicians, so that specific therapies and management
strategies can be applied to patients at high risk of
dying. However, only limited information is avail-
able for predictors of short-term mortality after
acute ischaemic stroke [3–7].
Patients and methods
Consecutive patients who presented within 24 hours
after symptom onset to our University Hospital-based
stroke center with a first-ever acute ischaemic stroke were
prospectively included from October 2003 to May 2007.
The local ethics committee approved the study.
Ischaemic stroke was diagnosed when neurological
deficits were accompanied by corresponding abnormal
findings depicted on brain computed tomography (CT)
and/or magnetic resonance imaging (MRI).
Patients with symptoms that had completely resolved
within 24 hrs (TIAs) were excluded.
Baseline clinical investigations included neurological
and physical examinations, routine blood analyses,and 12-
lead ECG. Stroke severity on admission was assessed with
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the National Institute of Health Stroke Scale (NIHSS)
[8]. Stroke etiology was classified using the Trial of Org
10172 in Acute Stroke Treatment (TOAST) criteria [9].
After initial clinical evaluation, patients underwent
nonenhanced CT followed by CT angiography (n = 229),
or multimodal MRI including axial T1-, T2-, and inter-
mediate-weighted SE images, diffusion-weighted images
(DWI), perfusion-weighted images (PWI), time-of-flight
magnetic resonance angiography (TOF-MRA), and gado-
linium diethylenetriamine penta-acetic acid enhanced
T1-weighted images (n = 234), or both CT and MRI
(n = 16).
One stroke neurologist who was blinded to clinical
details and outcomes, retrospectively analysed the images.
Early parenchymal CT signs of ischaemia were defined
according to the criteria by von Kummer et al. [10].DWI-
PWI mismatch was considered present when visual in-
spection indicated that the volume of the perfusion ab-
normality on the time-to-peak map exceeded the volume
of diffusion abnormality on the b = 1000 image by 20% or
more. Vessel occlusions at the time of initial CT angio-
graphy, TOF-MRA or digital subtraction angiography
were classified into:
1. Proximal: a) Internal carotid artery (ICA), b) M1
and M2 segments of the middle cerebral artery (MCA), c)
A1 segment of the anterior cerebral artery (ACA), d) V4
segment of the vertebral artery (VA), e) basilar artery
(BA), and f) P1 segment of the posterior cerebral artery
(PCA)
2.Distal: the more distal branches of theMCA,ACA,
and PCA, as well as cerebral infarcts with no visible vessel
occlusions.
Further diagnostic examination was left to the discre-
tion of the treating physician and included transoesopha-
geal or transthoracic echocardiography (TEE or TTE),
24-hours ECG, laboratory screening for cerebral vasculi-
tis, thrombophilia, and carotid ultrasound imaging.
The following stroke risk factors were assessed: age;
gender; hypertension (defined as a history of antihyper-
tensive treatment or a history of hypertension – systolic
blood pressure [BP] >140 mm Hg, diastolic BP >85 mm
Hg, or both –); diabetes mellitus (defined by preadmission
history or venous plasma glucose concentration of ≥7.0
mmol/l after an overnight fast on at least two separate
occasions, and/or ≥11.1 mmol/l two hours after the inges-
tion of 75 g of oral glucose and on one other occasion dur-
ing the 2-hour test), current cigarette smoking, hypercho-
lesterolemia (defined by preadmission history and/or total
cholesterol [TC] >5 mmol/l, and/or HDL-cholesterol <1
mmol/l, and/or LDL-cholesterol >3 mmol/l, and/or TC/
HDL ratio >5), history of coronary artery disease, and
positive family history of cerebrovascular ischaemic events.
Patients were treated according to European and
American guidelines and recommendations for acute
stroke treatment, secondary prevention and neurorehabil-
itation [11–13].
Information on serious medical and neurological
complications and the cause of death was obtained pro-
spectively from the medical records in our institution,
other hospitals or nursing homes where the patients were
discharged to, or the family physician. All deaths occur-
ring within 30 days after stroke were classified as due to
stroke, unless an undeniable other cause of death (myo-
cardial infarction, malignancy, car accident, etc.) was the
obvious cause of death [14].
Statistical analysis
Quantitative data are expressed as mean values ±
standard deviation. The NIHSS score for each patient at
admission is given as a median value. Data are reported in
frequency tables. Differences between groups and the
effect of patient characteristics on clinical outcome were
assessed using the Fisher Exact test (for comparison of
proportions), Student’s t test (for comparison of continu-
ous variables), and the Mann-Whitney U test (for com-
parison of ordinal variables). The Cox proportional-haz-
ards survival regression, which included variables that
showed statistical difference p ≤0.1 on univariate compar-
ison, was performed.
Results
Study population
During the study period, 479 patients (mean
age ± SD, 63 ± 14 years; range 18 to 92 years) were
admitted to our institution with a first-ever acute
ischaemic stroke. There were more men than
women (63% vs 37%). Of the 479 patients, 254
(53%) arrived within 3 hours, and 134 (28%) pre-
sented within 3 to 6 hours of symptom onset.
Twenty-six patients (5%) underwent intravenous
thrombolysis and 119 (25%) intra-arterial throm-
bolysis. Intravenous (<3 hours of symptom onset)
and intra-arterial thrombolysis (<6 hours of symp-
tom onset) were administered according to inter-
national guidelines and institutional protocols [15,
16]. The remaining 334 patients (70%) received
either 100–300 mg acetylsalicylic acid or 75 mg
clopidogrel within 24 hours after the stroke onset.
Follow-up data for mortality within 30 days
were available for 467 (97%) patients. These pa-
tients were included in the following univariate
and multivariate comparative analyses.
Baseline clinical characteristics
Table 1 shows the baseline clinical character-
istics of the 467 patients with first-ever acute is-
chaemic stroke. Hypertension was the most prev-
alent vascular risk factor (64%), followed by hyper-
cholesterolemia (55%), coronary artery disease
(34%), current cigarette smoking habit (32%),
positive family history of cerebrovascular ischae-
mic events (30%), and diabetes mellitus (14%).
The median NIHSS score was 6 (range 1–38).
Seventy-four percent of all strokes were local-
ized in the distribution of the carotid arteries.The
remaining 26% were localised in the vertebro-
basilar circulation.
The identified causes of stroke were cardiac
embolism in 33%, large artery arteriosclerosis in
14%, small vessel disease in 10%, other deter-
mined etiologies in 11%, and multiple causes in
1%. Stroke etiology remained undetermined in
30% of cases despite extensive examination.
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Table 1
Presenting clinical characteristics of 467 patients with a first-ever ischaemic stroke.
Characteristics, n (%) Survivors
(n = 405)
Deceased within 30 days
(n = 62)
p-value
Male gender 259 (64) 37 (60) 0.51
Mean age, yr (SD) 61 (14) 74 (10) <0.001
Vascular risk factors
Hypertension 251 (62) 50 (80) 0.013
Diabetes mellitus 51 (13) 14 (23) 0.069
Hypercholesterolemia 223 (55) 33 (54) 0.86
Current cigarette smoking 134 (33) 14 (23) 0.27
History of coronary artery disease 124 (31) 35 (57) 0.001
Positive familial history 117 (29) 23 (38) 0.48
Median NIHSS score (range) 6 (1–38) 14 (1–38) <0.001
Stroke location
Carotid artery territory 298 (74) 46 (74) 0.92
Vertebrobasilar territory 107 (26) 16 (26) 0.92
Stroke etiology
Large artery atherosclerosis 59 (15) 7 (11) 0.49
Cardiac embolism 131 (32) 24 (39) 0.32
Small vessel disease 44 (11) 2 (3) 0.06
Other determined 49 (12) 3 (5) 0.09
Undetermined 115 (28) 26 (42) 0.031
Multiple causes 7 (2) – 0.3
Charlson index, median (range) 0 (0 to 6) 1 (0 to 15) 0.008
SD: standard deviation.
NIHSS: National Institutes of Health Stroke Scale.
Table 2
Ancillary Examinations and Thrombolysis in 467 patients with a first-ever ischaemic stroke.
Characteristics Survivors
(n = 405)
Deceased
within 30 days
(n = 62)
p-value
Blood glucose on admission, mean (SD), mmol/l 7.1 (2.3) 8.1 (2.1) <0.001
BP on admission, mean (SD), mm Hg
Systolic 155 (25) 160 (31) 0.38
Diastolic 80 (16) 84 (16) 0.11
Atrial fibrillation, n (%) 62 (14) 25 (40) <0.001
Early parenchymal CT signs of ischemia
1
81 (41) 26 (79) <0.001
Dense artery sign 32 (15) 18 (54) <0.001
DWI/PWI mismatch
2
85 (39) 15 (45) 0.49
Proximal vessel occlusion 148 (37) 43 (70) <0.001
Thrombolysis
Intra-arterial 93 (23) 24 (39) 0.008
Intravenous 21 (5) 5 (8) 0.36
Symptomatic intracerebral haemorrhage after
thrombolysis
6 (5) 8 (28) <0.001
1
From 245 patients who underwent CT and CT angiography.
2
From 250 patients who underwent MRI and MR angiography.
Baseline ancillary examinations
Table 2 gives the results of the baseline ancil-
lary examinations.The mean blood glucose on ad-
mission was 7.24 ± 2.3 mmol/l. The mean systolic
BP at presentation was 156 ± 26 mm Hg, and the
diastolic BP was 81 ± 16 mmHg.Atrial fibrillation
was diagnosed in 44 patients (9%). Early paren-
chymal CT signs of ischaemia were present in 107
of 245 patients (44%), who underwent CT and
CT angiography on admission.A dense artery sign
was visualised in 40 CT scans (16%). Among the
250 patients who underwent an MRI and MRA,
a DWI/PWI mismatch was present in 100 (40%)
patients. Overall, 191 patients (41%) showed a
proximal vessel occlusion on CT and/or MR
angiography.
Early mortality
Sixty-two patients (13%) died within 30 days
of their first stroke.The cause of death was the ini-
tial event in 43 of 62 patients (69%), pneumonia in
12 (19%), intracerebral haemorrhage in 9 (15%),
recurrent stroke in 6 (10%), and myocardial in-
farction in 2 (3%). One patient (2%) died of carci-
noma of the kidney. Stroke etiology was large
artery disease in 7 patients (11%), small artery
disease in 2 patients (3%), cardioembolism in
24 patients (39%), other determined etiology in
4 patients (6%), and undetermined cause in 25 pa-
tients (40%).
Predictors of early mortality
In univariate analysis, advanced age (p <0.001),
hypertension (p = 0.013), coronary artery disease
(p = 0.001), high NIHSS score on admission
(p <0.001), undetermined stroke etiology despite
extensive diagnostic examination (p = 0.031), rel-
evant comorbidities as measured with the Charl-
son index (p = 0.008), hyperglycaemia on admis-
sion (p <0.001), atrial fibrillation (p <0.001), early
parenchymal CT signs of ischaemia (p <0.001),
dense artery sign (p <0.001), proximal vessel occlu-
sion as seen on CT orMR angiography (p <0.001),
and intra-arterial thrombolysis (p = 0.008) were
associated with early mortality.
Cox-proportional hazards survival regression
revealed advanced age and a high NIHSS on ad-
mission as independent predictors of early mortal-
ity (table 3).
Table 3
Independent predictors of early mortality in 467 patients
with first-ever ischaemic stroke.
Variable Hazard ratio 95% CI p-value
Advanced age 1.12 1.05–1.19 <0.001
High NIHSS on admission 1.15 1.05–1.25 0.001
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In this sample of 467 patients, 13% died
within 30 days of their first-ever stroke.The initial
event was by far the most common cause of death
(69% of patients). Other causes were pneumonia
(19%), intracerebral haemorrhage (15%), recur-
rent stroke (10%), myocardial infarction (3%),
and cancer (2%). Advanced age and high NIHSS
on admission were the only predictors of early
mortality. These are the main results of the pres-
ent study.
How does the 13%mortality rate, in this sam-
ple, rank in the light of previous studies? A recent
study assessed the 30-day mortality in the original
Framingham and the Framingham offspring co-
horts [1]. Over a follow-up period of 50 years, 30-
day mortality decreased significantly in men (from
23% to 14%), but not significantly in women
(from 21% to 20%). In the present series, we did
not observe gender differences in early mortality
after ischaemic stroke (13% in men and 15% in
women, p = 0.51). In a study from the Department
of Veterans Affairs (VA), 34866 patients with first-
ever ischaemic stroke were retrospectively identi-
fied. The authors reported 8.2% mortality at 30
days after the stroke [4]. De Jong et al. observed
similar rates (10% mortality at 30 days) in 998 pa-
tients with first-ever cerebral infarction [3]. At the
same time, Rothwell et al. reported a 17.2% case-
fatality due to initial stroke in the Oxford Com-
munity Stroke Project (OCSP, 1981–1984) and
17.8% in the Oxford Vascular Study (OXVASC,
2002–2004) [2]. The 30-day mortality rate in this
study is in the lower range of the figures reported
in the literature. Our findings show a lower stroke
mortality rate in Switzerland compared with other
industrialised and developing countries from dif-
ferent parts of the world [17]. However, such a
comparison is unjustified, because patients admit-
ted to a tertiary care center are highly selected.
Several factors are known to influence early
mortality. Among them, age and stroke severity
have been most consistently reported. The age
range of a first stroke in the Framingham and the
Framingham offspring cohorts was 69–76 years in
men and 69–81 years in women [1].The study did
not explicitly assess the influence of age on 30-day
mortality; although a previous study from Fram-
ingham had shown that advanced age at initial
stroke was independently associated with a high
30-day mortality [18]. Collins et al. grouped their
patients with ischaemic stroke into five age catego-
ries: under 45 years (2.4%), 45–54 years (10.3%),
55–64 years (21.9%), 65–74 years (39.1%), and 75
years and older (26.3%) [4]. The risk factor asso-
ciated with the highest hazard for a 30-day mor-
tality was advanced age (75 years and older) (HR
4.47; 95% CI 3.03–6.60). Advanced age, along
with diabetes and stroke subtype, was also an inde-
pendent predictor of 30-day case fatality in the
study by de Jong et al. [3]. In a recent study of 469
older patients (mean age: 80 years), 130 subjects
(27.7%) died within 30 days after stroke [7]. Mul-
tivariate logistic regression analysis indicated that
short-term mortality was associated with age, al-
tered level of consciousness and congestive heart
failure. In the current sample, the mean age was 63
years in men and 64 years in women. Increasing
age was significantly associated as a hazard for
early mortality (HR = 1.12; 95% CI 1.05–1.19).
Stroke severity on admission is a well-estab-
lished predictor of mortality. Several clinical vari-
ables that reflect the severity of the neurologic le-
sion have been analysed to predict the clinical out-
come. Level of consciousness was the main clinical
predictor of early mortality in many previous stud-
ies [19–23]. Dysphagia and body temperature have
also been reported to predict 30-day mortality af-
ter stroke [24–27]. Prognostic models taking into
account the severity of motor paresis are scarce.
The NIHSS scale, which is a validated tool for as-
sessing the initial stroke severity, accurately pre-
dicted the 3-month clinical outcome in previous
studies [28, 29]. In the present study, the NIHSS
score on admission was associated with an HR =
1.15 (95% CI 1.05–1.25) for 30-day mortality.
Low admission BP, elevated pulse pressure, el-
evated serum urea levels in patients with diabetes,
hyperglycaemia in nondiabetic patients, and the
presence of atrial fibrillation have been associated
with poor clinical outcome and increased mortal-
ity 3 months after stroke onset [30–36]. In our
study, hyperglycaemia on admission and the pres-
ence of atrial fibrillation were associated with a
30-day mortality in univariate but not in multivar-
iate analysis. It may be that blood glucose levels
and atrial fibrillation are related to age and/or
stroke severity, thus, the effects they exert on mor-
tality are not independent. The same is true for
the association of intra-arterial thrombolysis and
early mortality. With univariate analysis they are
associated, after multivariate analysis not. Both
mean age and median NIHSS score were signifi-
cantly higher in patients who died than in survi-
vors.This suggests that age and higher NIHSS ac-
count for the higher mortality and not thrombo-
lysis.A history of hypertension was associated with
a 30-day mortality in univariate analysis but ad-
mission BP was not. Previous studies have shown
considerable variations of BP in the acute phase of
ischaemic stroke [30]. Variables describing the
course of BP over the first 2.5 days have a marked
and independent relationship with the outcome at
30 days.
CT and early perfusion- and diffusion-
weighted MRI have been shown to predict fatal
outcome in patients with extensive middle cere-
bral artery infarction [37, 38].One of the strengths
of the present study is the extensive evaluation of
our studied population with modern imaging
technologies. All patients underwent CT and CT
angiography and/or MRI and MR angiography.
The presence of early CT signs of parenchymal
Discussion
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ischaemia or dense artery signs, as well as the CT-
or MR-angiographic demonstration of proximal
vessel occlusion were significantly associated with
a 30-day mortality in univariate analysis (table 2).
However, there were no independent radiological
predictors of early mortality in multivariate analy-
sis. Obviously, there is a strong correlation be-
tween stroke severity as measured with the NI-
HSS and the above CT and MRI findings. The
relationship of proximal vessel occlusion and the
NIHSS in acute stroke has been shown in a previ-
ous correlative study of the NIHSS and digital
subtraction arteriography [39].
Our study has the limitation of being a hospi-
tal-based study population. Although our institu-
tion is the main stroke center for the canton of
Bern and serves a catchment area for almost 1.5
million inhabitants, patients with acute ischaemic
stroke included in the present study are not repre-
sentative of the entire population. In particular,
patients who die from their stroke before admis-
sion to our hospital have not been analysed. Fur-
thermore, younger stroke victims are more likely
to be referred to a university-based stroke center
than older patients with stroke. Consequently, our
patients are approximately 10 years younger than
would have been expected in a population-based
study.
To summarise, the present study reports a
13%mortality rate at 30 days after acute ischaemic
stroke. More than two thirds of the deaths were
related to the index event. Advanced age and
stroke severity on admission were the only inde-
pendent predictors of early mortality, whilst the
results of the laboratory investigations and brain
imaging had no independent prognostic value.
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